Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pamela J. Farrell"'
Autor:
Patrick Vincent, Barbara Hibner, Ron de Jong, Hidehisa Iwata, Akio Mizutani, Akira Hori, Kengo Okada, J. David Lawson, Shaosong Chu, Ruhi Kamran, Mark S. Hixon, Shweta Pandya, Deepika Balakrishna, Jennifer Matuszkiewicz, Pamela J. Farrell
Supplemental Table 1. Activity of MET TKIs in enzyme and cellular assessments Supplemental Table 2. Activity of Compound 1 against approximately 130 additional protein kinases. Figure S1. Binding modes of selective MET TKIs. Figure S2. MET TKI, Compo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120f016d9ddd8b8907dbb9ab603d8673
https://doi.org/10.1158/1535-7163.22504134
https://doi.org/10.1158/1535-7163.22504134
Autor:
Patrick Vincent, Barbara Hibner, Ron de Jong, Hidehisa Iwata, Akio Mizutani, Akira Hori, Kengo Okada, J. David Lawson, Shaosong Chu, Ruhi Kamran, Mark S. Hixon, Shweta Pandya, Deepika Balakrishna, Jennifer Matuszkiewicz, Pamela J. Farrell
Receptor tyrosine kinase therapies have proven to be efficacious in specific cancer patient populations; however, a significant limitation of tyrosine kinase inhibitor (TKI) treatment is the emergence of resistance mechanisms leading to a transient,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a781388f16b2563b61d0736ccfdad587
https://doi.org/10.1158/1535-7163.c.6537630
https://doi.org/10.1158/1535-7163.c.6537630